$-0.02 EPS Expected for Point Loma Resources Ltd. (PLX); Brookside Capital Management Raised Immune Design (IMDZ) Holding

May 16, 2018 - By Michael Collier

Analysts expect Point Loma Resources Ltd. (CVE:PLX) to report $-0.02 EPS on May, 29.They anticipate $0.01 EPS change or 33.33% from last quarter’s $-0.03 EPS. The stock decreased 3.57% or $0.01 during the last trading session, reaching $0.27. About 8,500 shares traded. Point Loma Resources Ltd. (CVE:PLX) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Brookside Capital Management Llc increased Immune Design Corp (IMDZ) stake by 155.33% reported in 2017Q4 SEC filing. Brookside Capital Management Llc acquired 2.02M shares as Immune Design Corp (IMDZ)’s stock declined 10.42%. The Brookside Capital Management Llc holds 3.32 million shares with $12.94M value, up from 1.30 million last quarter. Immune Design Corp now has $206.94M valuation. The stock increased 8.86% or $0.35 during the last trading session, reaching $4.3. About 613,265 shares traded or 84.24% up from the average. Immune Design Corp. (NASDAQ:IMDZ) has declined 53.26% since May 16, 2017 and is downtrending. It has underperformed by 64.81% the S&P500.

Point Loma Resources Ltd. engages in the acquisition, development, and production of petroleum and natural gas reserves in the province of Alberta, Canada. The company has market cap of $12.50 million. It holds 80% working interests in approximately 120,000 net acres in the Greater Paddle River area located to the west of Edmonton, Alberta. It currently has negative earnings.

More recent Point Loma Resources Ltd. (CVE:PLX) news were published by: Seekingalpha.com which released: “Protalix: Valuable, Misunderstood, And Deeply Mispriced” on May 10, 2018. Also Seekingalpha.com published the news titled: “How De-Risked Is Protalix’s Fabry Superiority Trial?” on May 15, 2018. Seekingalpha.com‘s news article titled: “Protalix BioTherapeutics’ (PLX) CEO Moshe Manor on Q1 2018 Results – Earnings Call Transcript” with publication date: May 09, 2018 was also an interesting one.

More news for Immune Design Corp. (NASDAQ:IMDZ) were recently published by: Seekingalpha.com, which released: “Immune Design Nearing Critical Point In Valuation” on May 11, 2018. Seekingalpha.com‘s article titled: “Immune Design’s (IMDZ) CEO Dr. Carlos Paya on Q1 2018 Results – Earnings Call Transcript” and published on May 03, 2018 is yet another important article.

Investors sentiment increased to 1.92 in 2017 Q4. Its up 0.65, from 1.27 in 2017Q3. It increased, as 14 investors sold IMDZ shares while 12 reduced holdings. 24 funds opened positions while 26 raised stakes. 23.09 million shares or 94.39% more from 11.88 million shares in 2017Q3 were reported. Balyasny Asset Mgmt Ltd Com holds 0% or 49,012 shares in its portfolio. American Intl Gru has invested 0% of its portfolio in Immune Design Corp. (NASDAQ:IMDZ). Alyeska Inv Group Inc Ltd Partnership holds 0.02% or 500,000 shares. The Massachusetts-based Crow Point Prns Ltd Liability Corp has invested 0% in Immune Design Corp. (NASDAQ:IMDZ). Voya Investment stated it has 0% in Immune Design Corp. (NASDAQ:IMDZ). Abingworth Ltd Liability Partnership invested in 352,300 shares or 1% of the stock. State Of Wisconsin Invest Board stated it has 12,000 shares or 0% of all its holdings. Pnc Services Gru Incorporated reported 113 shares. Proquest Assoc Iv Lc has 6.4% invested in Immune Design Corp. (NASDAQ:IMDZ) for 1.24 million shares. Rhumbline Advisers holds 0% or 16,398 shares. Royal Financial Bank Of Canada owns 3,215 shares. Legal General Grp Inc Plc invested 0% of its portfolio in Immune Design Corp. (NASDAQ:IMDZ). Personal Advsr Corp has 0% invested in Immune Design Corp. (NASDAQ:IMDZ) for 24,000 shares. Bvf Il invested in 1.47M shares. Manufacturers Life The has 0% invested in Immune Design Corp. (NASDAQ:IMDZ).

Brookside Capital Management Llc decreased Honeywell Intl Inc (NYSE:HON) stake by 132,432 shares to 237,085 valued at $36.36M in 2017Q4. It also reduced Clovis Oncology Inc (Call) (NASDAQ:CLVS) stake by 208,851 shares and now owns 3,000 shares. Meridian Bancorp Inc Md (NASDAQ:EBSB) was reduced too.

Immune Design Corp. (NASDAQ:IMDZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: